TP53 and neoplasm: The higher DNA repair efficiency in the 72Pro cell lines compared to the 72Arg cells [77] and the lower apoptotic activity of the variant may result in a worse therapy response, although it has been reported that the impact of rs1042522 on the clinical outcome may depend on the p53 mutation status of the tumor [78].